Nitrilase cross-linked enzyme aggregate as well as preparation method and application thereof

Through the preparation of nitrile hydrolase crosslinked enzyme aggregates, the problems of poor stability and high cost in the synthesis and degradation of drug intermediates and nitrile substances are solved, and efficient and low-cost catalytic effect is achieved.

CN118931887APending Publication Date: 2024-11-12ZHEJIANG UNIV OF TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410856952.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-28
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

Nitrile hydrolase has poor stability, high cost and difficulty in recycling in the synthesis and degradation of drug intermediates and nitrile substances, which limits its industrial applications.

Method used

Using the preparation method of nitrile hydrolase crosslinking enzyme aggregates (CLEAs), nitrile hydrolase crosslinking enzyme aggregates with high specific enzyme activity and high enzyme activity recovery are prepared through precipitation, aggregation, crosslinking and stabilization processes, simplifying the The process and reduce costs.

Benefits of technology

The efficient conversion and multiple reuse of nitrile hydrolase are achieved, which significantly improves batch stability and catalytic capacity and reduces the preparation and use cost.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure HDA0004918308260000011
    Figure HDA0004918308260000011
  • Figure HDA0004918308260000021
    Figure HDA0004918308260000021
Patent Text Reader

Abstract

The invention discloses a nitrilase cross-linked enzyme aggregate and a preparation method and application thereof.According to the nitrilase cross-linked enzyme aggregate and the preparation method and application thereof, nitrilase CLEAs is prepared from crude enzyme, the preparation process comprises the four steps of precipitation, aggregation, cross-linking and stabilization, the operation process is simple, the cost is reduced, enlarged production is easier, and equipment is not depended on. The AcN-T nitrilase CLEAs catalyst prepared by the method has an enzyme activity recovery rate up to 60%, can continuously catalyze 200 mM of a substrate (1-cyanocyclohexyl hexanenitrile) to completely convert for 45 batches, and has good batch stability. The immobilized enzyme prepared by the method provided by the invention can catalyze different substrates to synthesize corresponding products, can tolerate high substrate concentration and realizes complete conversion of the substrates. The immobilized enzyme prepared by the method provided by the invention has higher catalytic activity and excellent operation stability, can be used for efficiently preparing pharmaceutical chemicals or degrading nitrile substances under mild conditions, and has higher industrial value.
Need to check novelty before this filing date? Find Prior Art

Description

(I) Technical field

[0001] The invention belongs to the technical field of bioengineering, and specifically relates to a nitrilase cross-linked enzyme aggregate and a preparation method thereof, as well as applications in preparing 1-cyanocyclohexylacetic acid, (R)-o-chloromandelic acid and degrading ricinine. (II) Background technology

[0002] Nitrilase (EC.3.5.5.1) is a green biocatalyst that can hydrolyze nitrile compounds into corresponding carboxylic acids and ammonia. It is widely used in the synthesis of pharmaceutical intermediates, chemical intermediates, carboxylic acid products with specific chiral centers, and the degradation of nitrile substances. Compared with chemical synthesis, nitrilase catalysis has the advantages of mild reaction conditions, good selectivity, and less discharge of three wastes.

[0003] For example, Gabapentin, whose chemical name is 1-(aminomethyl)-cyclohexylacetic acid, is a first-line drug for the treatment of epilepsy and neuropathic pain. Its chemical synthesis method is limited by raw materials, strong acids and bases, organic reagents, and extreme reaction conditions, and there are many problems. The chemical-enzymatic method of synthesizing the key intermediate 1-cyanocyclohexylacetic acid (1-CA) by regioselective hydrolysis catalyzed by nitrilase using 1-cyanocyclohexylacetonitrile (1-CN) as a substrate is green and efficient. (R)-O-chloromandelic acid is a key precursor for the synthesis of the drug clopidogrel, and its preparation methods include racemic resolution and asymmetric synthesis. The incomplete stereoselectivity of the chiral resolution reagent in the racemic resolution method will lead to the production of the byproduct (S)-O-chloromandelic acid, while the chemical synthesis method has strict requirements on reaction conditions, and the required catalyst is expensive, difficult to recover, and seriously polluting. The method of using stereoselective nitrilase to chirally resolve racemic o-chloromandelonitrile to produce (R)-o-chloromandelic acid can utilize the spontaneous racemization characteristics of o-chloromandelonitrile and the strict stereoselectivity of nitrilase (ee>99.9%) to efficiently catalyze and synthesize highly optically pure (R)-o-chloromandelic acid, with high product yield, mild reaction conditions and green and pollution-free. Nitrilase can also be used for the degradation of nitrile substances, such as ricin, amygdalin, etc., and utilizes the non-toxic and pollution-free characteristics of biological catalysts to make the degraded substances free of harmful residues. Although the nitrilase method has many advantages in catalyzing the synthesis of 1-cyanocyclohexylacetic acid and (R)-o-chloromandelic acid, and in the degradation of nitrile substances, nitrilase has poor stability and reusability compared with other industrial enzymes, and the free nitrilase or cell catalyst after use is difficult to separate from the product, and the cost of the catalyst for one-time use is also relatively high, which limits its industrial application.

[0004] Immobilized nitrilase can solve the above defects. Immobilized enzymes can improve tolerance to extreme environments while retaining the catalytic activity of the enzyme; immobilized enzymes can also be completely separated from substrates / products by filtration, centrifugation and other operations and recycled, reducing the cost of enzyme use and product separation costs. Enzyme immobilization can be divided into two methods: with carriers and without carriers. Carrier-immobilized enzymes may cause changes in the enzyme structure, resulting in loss of enzyme activity, and immobilized carriers may also limit the diffusion of substrates; while carrier-free immobilized enzymes do not use carriers, and the enzyme can be directly cross-linked to obtain. Carrier-free immobilized enzymes mainly include cross-linked enzyme crystals (CLECs), cross-linked spray-dried enzymes (CLSDs) and cross-linked enzyme aggregates (CLEAs). Among them, cross-linked enzyme aggregates (CLEAs) use cross-linking agents to connect enzyme molecules with covalent bonds, thereby immobilizing the enzyme and stabilizing it. Its preparation generally includes two major steps: enzyme precipitation and enzyme aggregate cross-linking. CLEAs avoid the shortcomings of carriers, with high enzyme loading and enzyme activity recovery rates; and can simplify the preparation process, that is, crude enzyme solution is used instead of pure enzyme solution for preparation. CLEAs have been well applied in the immobilization of enzymes such as lipase, amylase, and hydrolase. For example, CN109136212A discloses a malathion hydrolase CLEA, whose specific activity is 5 times that of conventional CLEAs; it has good reusability, and the residual enzyme activity is about 86% after 10 uses; the residual activity is maintained at more than 65% at 50°C, and 0.15mM malathion can be completely hydrolyzed within 15 minutes.

[0005] Based on literature research, it was found that previously reported immobilized nitrilase was mainly diatomaceous earth cross-linked cells, alginate hydrogel embedded cells, resin adsorbed enzymes, biomimetic silicon embedded enzymes, etc. The activity of its catalyst is limited by the carrier and enzyme loading. For example, alginate hydrogel embedded cells have a low catalyst loading, and the hydrogel causes obvious mass transfer resistance to the substrate. Carrier-immobilized enzymes are also prone to catalyst leakage during batch reactions. Using CLEAs technology, it is expected to prepare low-cost, high-enzyme loading, low activity loss, and high-stability immobilized nitrilase, thereby achieving efficient preparation of pharmaceutical chemicals or degradation of nitrile substances in oil cakes. (III) Summary of the invention

[0006] The present invention aims to provide a nitrilase cross-linked enzyme aggregate (CLEAs) and a preparation method and application thereof, so as to realize the efficient synthesis of gabapentin intermediate 1-cyanocyclohexylacetic acid and clopidogrel key precursor (R)-o-chloromandelic acid, or to degrade ricinine in castor cake. The present invention uses crude nitrilase as raw material, and through precipitation, aggregation, cross-linking, stabilization and other processes, the prepared nitrilase CLEAs have high specific enzyme activity and high enzyme activity recovery rate, can realize efficient conversion of substrate to product, and can be repeatedly used; its preparation cost is greatly reduced compared with traditional immobilized enzymes, and batch stability is greatly improved.

[0007] The technical solution adopted by the present invention is:

[0008] The present invention provides a nitrilase cross-linked enzyme aggregate (denoted as CLEAs), wherein the nitrilase cross-linked enzyme aggregate is prepared according to the following steps:

[0009] (1) suspending wet cells obtained from an engineered bacterium containing a nitrilase encoding gene in a pH 6-8 sodium phosphate buffer (preferably 200 mM, pH 7.0), ultrasonically disrupting the cells, centrifuging the cells, and collecting the supernatant to obtain a crude nitrilase enzyme solution;

[0010] (2) In a constant temperature water bath at 35° C., a precipitant is added to the crude enzyme solution, and the solution is allowed to stand for 10 minutes to precipitate the protein; a surfactant is then added, and the solution is allowed to stand for 10 minutes to aggregate the protein; a cross-linking agent is then added, and the solution is reacted at 600 rpm for 0.5-3 hours (preferably 1 hour) to cross-link the protein; a stabilizer is finally added, and the solution is reacted at 600 rpm for 10 minutes to stabilize the protein, the reaction solution is washed with water for 3-5 times, and centrifuged (at 4° C., 8000 rpm for 10 minutes), and the precipitate is collected to obtain nitrilase cross-linked enzyme aggregates (CLEAs); the precipitant is one of ammonium sulfate, acetonitrile, ethanol, and acetone; the stabilizer is one of bovine serum albumin, tryptophan, lysine, and tyrosine, preferably bovine serum albumin.

[0011] Furthermore, the nitrilase in step (1) includes nitrilase AcN-T (nucleotide sequence as shown in SEQ ID NO.1, amino acid sequence as shown in SEQ ID NO.2), nitrilase ZJUTB10 (nucleotide sequence as shown in SEQ ID NO.3, amino acid sequence as shown in SEQ ID NO.4) or nitrilase J1-M1 (nucleotide sequence as shown in SEQ ID NO.5, amino acid sequence as shown in SEQ ID NO.6).

[0012] Furthermore, in step (1), the frequency of ultrasonic crushing is 1s crushing and 2s resting, and the power is 240W.

[0013] Furthermore, the protein concentration of the crude enzyme solution in step (2) is 5-10 mg / mL, preferably 5 mg / mL.

[0014] Furthermore, the precipitant in step (2) is solid ammonium sulfate; the amount of the precipitant added is 10-396 g / L, preferably 20 g / L, based on the volume of the crude enzyme solution.

[0015] Furthermore, the surfactant in step (2) is one of betaine, fatty acid glyceride, Tween 80, and polyether Pluronic-F127, preferably betaine; and the amount of the surfactant added is 5-20 g / L, preferably 15 g / L, based on the volume of the crude enzyme solution.

[0016] Furthermore, the cross-linking agent in step (2) is one of glutaraldehyde, pectin, polyethyleneimine, and 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC), preferably glutaraldehyde; and the amount of the cross-linking agent added is 5-20 g / L, preferably 10 g / L, based on the volume of the crude enzyme solution.

[0017] Furthermore, the amount of the stabilizer added in step (2) is 1-5 g / L, preferably 2 g / L, based on the volume of the crude enzyme solution.

[0018] The present invention also provides an application of the nitrilase cross-linked enzyme aggregate in preparing compound intermediates, wherein the compound intermediates include gabapentin intermediate 1-cyanocyclohexylacetic acid and clopidogrel intermediate (R)-o-chloromandelic acid.

[0019] Further, the application of the nitrilase cross-linked enzyme aggregate in the preparation of gabapentin intermediate 1-cyanocyclohexyl acetic acid is carried out according to the following steps: CLEAs prepared by nitrilase AcN-T is used as a catalyst, 1-cyanocyclohexyl acetonitrile is used as a substrate, and 200mM, pH 7.0 sodium phosphate buffer is used as a reaction medium to form a reaction system, react at 35°C and 600rpm, separate and purify the reaction solution, and recover the catalyst for reuse to obtain 1-cyanocyclohexyl acetic acid. The catalyst is added to a final concentration of 5-15g / L, preferably 8.41g / L; the substrate is added to a final concentration of 200-1000mM, preferably 200mM.

[0020] Further, the application of the nitrilase cross-linked enzyme aggregate in the preparation of clopidogrel intermediate (R)-o-chloromandelic acid is carried out according to the following steps: CLEAs prepared by nitrilase ZJUTB10 are used as catalysts, racemic o-chloromandelic acid is used as substrate, 200mM, pH 8.0 sodium phosphate buffer is used as reaction medium to form a reaction system, react at 35°C and 600rpm, recover the catalyst for repeated use, and obtain the product (R)-o-chloromandelic acid. The catalyst is added at a final concentration of 5-15g / L, preferably 9.89g / L; the substrate is added at a final concentration of 100-500mM.

[0021] The present invention also provides an application of a nitrilase cross-linked enzyme aggregate in degrading ricinine in castor meal, the application being carried out according to the following steps: using CLEAs prepared by nitrilase J1-M1 as a catalyst, using castor meal as a substrate, and using 200 mM, pH 7.0 sodium phosphate buffer as a reaction medium to form a reaction system, and culturing at 37° C. and 300 rpm to achieve degradation of ricinine. The mass ratio of the catalyst to the substrate is 1:800-1000, preferably 1:1000; the volume dosage of the buffer is 0.1-1 mL / mg, preferably 0.4 mL / mg, based on the mass of the catalyst.

[0022] Compared with the prior art, the beneficial effects of the present invention are mainly reflected in:

[0023] (1) The present invention uses crude enzyme solution to prepare nitrilase CLEAs. The preparation process includes four steps: precipitation, aggregation, cross-linking, and stabilization. The operation process is simple, the cost is reduced, and it is easier to scale up production without relying on equipment.

[0024] (2) The immobilization rate of AcN-T nitrilase CLEAs prepared according to the method of the present invention reached 81%, the specific enzyme activity reached 5.68 U / mg, and the enzyme activity recovery reached 60%. Both the immobilization rate and the enzyme activity were high.

[0025] (3) AcN-T nitrilase CLEAs prepared according to the method of the present invention can completely convert 200mM substrate within 3h, 500mM substrate within 6h, and 1000mM substrate within 11h; ZJUTB10 nitrilase CLEAs prepared according to the method of the present invention can completely convert 100mM substrate within 3h, 200mM substrate within 6h, and 500mM substrate within about 16h. J1-M1 nitrilase CLEAs prepared according to the method of the present invention can degrade the ricinine concentration in castor cake from 0.31% to <0.02% within 48h. The nitrilase CLEAs prepared by the present method have good catalytic ability for high-concentration substrates, and the immobilization method provided by the present invention can be applied to the preparation of different nitrilase CLEAs.

[0026] (5) The AcN-T nitrilase CLEAs prepared by the present invention can completely convert 200 mM substrate in 45 batches of reactions in the batch reaction of preparing 1-cyanocyclohexylacetic acid, showing excellent reusability and stability. (IV) Description of the drawings

[0027] Figure 1 Are plasmid maps; a represents the map of expression plasmid pET28b-AcN-T, b represents the map of expression plasmid pET28b-ZJUTB10, and c represents the map of expression plasmid pET28b-J1-M1.

[0028] Figure 2 The standard curve of nitrilase protein concentration (a) and the flow chart of CLEAs preparation (b) are shown.

[0029] Figure 3 are the effects of precipitant type and concentration on CLEAs precipitation rate and enzyme activity recovery rate, respectively; a is the effect of precipitant type on protein precipitation rate; b is the effect of precipitant concentration on enzyme activity recovery rate; c is the effect of ammonium sulfate of different concentrations and different physical states (s: solid, l: solution) on enzyme activity recovery rate.

[0030] Figure 4 The effects of surfactant type and dosage on the recovery rate of CLEAs enzyme activity.

[0031] Figure 5 The effects of cross-linking agent type, dosage and cross-linking time on the recovery rate of CLEAs enzyme activity. a shows the effects of cross-linking agent type and dosage on the recovery rate of enzyme activity; b shows the effects of cross-linking time on the recovery rate of enzyme activity.

[0032] Figure 6 The effects of stabilizer type and dosage on the recovery rate of CLEAs enzyme activity.

[0033] Figure 7 The effect of different concentrations of 1-cyanocyclohexylacetonitrile on the CLEAs-catalyzed reaction.

[0034] Figure 8 This is the effect of different concentrations of racemic o-chloromandelonitrile on the CLEAs-catalyzed reaction.

[0035] Fig. 9 The catalytic batch stability of CLEAs in the catalytic synthesis of 1-cyanocyclohexylacetic acid.

[0036] Fig.10 This is a process diagram of ricinine degradation by J1-M1 nitrilase CLEAs. (V) Specific implementation methods

[0037] The present invention is further described below in conjunction with specific embodiments, but the protection scope of the present invention is not limited thereto:

[0038] Example 1: Construction of nitrilase genetically engineered bacteria

[0039] In this embodiment, the LB liquid medium is composed of: 5g / L yeast powder, 10g / L tryptone, 10g / L sodium chloride, the solvent is water, and the pH does not need to be adjusted additionally. The LB solid medium is LB liquid medium with 15g / L agar added thereto.

[0040] (1) Construction of genetically engineered bacteria producing nitrilase AcN-T: Using the AcN-T genomic DNA described in patent CN111172140B as a template, high-fidelity Pfu DNA polymerase was used for PCR amplification under the initiation of primers 1 and 2 (see Table 1 for details) to obtain the gene sequence of nitrilase AcN-T (nucleotide sequence is shown in SEQ ID NO.1, and the amino acid sequence of the encoded protein is shown in SEQ ID NO.2). After sequencing, the amplified fragment was treated with BspHI and BsiWI (GTACC) restriction endonucleases (TaKaRa), and the fragment was ligated with a commercial vector pET28b (Invitrogen) treated with the same restriction endonuclease using T4 DNA ligase (TaKaRa) to construct an expression vector pET28b-AcN-T. The plasmid map is shown in Figure 1 The vector was transformed into Escherichia coli BL21 (DE3) (42°C, 90s), spread on an LB plate containing 50 μg / mL kanamycin resistance, and cultured at 37°C for 8-12h. The clones were randomly selected and the plasmids were extracted for sequencing and identification, and the recombinant Escherichia coli BL21 (DE3) / pET28b-AcN-T containing the vector was screened.

[0041] (2) Construction of genetically engineered bacteria producing nitrilase ZJUTB10: Using the ZJUTB10 genomic DNA contained in patent CN101629192B as a template, the gene sequence of nitrilase ZJUTB10 (nucleotide sequence is shown in SEQ ID NO.3, and the amino acid sequence of the encoded protein is shown in SEQ ID NO.4) was obtained under the initiation of primers 3 and 4 (details are shown in Table 1). The construction method of the expression vector pET28b-ZJUTB10 and the recombinant Escherichia coli BL21 (DE3) / pET28b-ZJUTB10 containing the vector is the same as (1), and the plasmid map is shown in Figure 1 Middle b.

[0042] (3) Construction of genetically engineered bacteria producing nitrilase J1-M1: Using the genomic DNA of the nitrilase mutant Nit-RR-J1-W166G / N164A (hereinafter referred to as J1-M1) described in patent CN117965504A as a template, the gene sequence of nitrilase J1-M1 (nucleotide sequence is shown in SEQ ID NO.5, and the amino acid sequence of the encoded protein is shown in SEQ ID NO.6) was obtained under the initiation of primers 5 and 6 (see Table 1 for details). The construction method of the expression vector pET28b-J1-M1 and the recombinant Escherichia coli BL21 (DE3) / pET28b-J1-M1 containing the vector is the same as (1), and the plasmid map is shown in Figure 1 Middle c.

[0043] (4) Cultivation of engineered bacteria: The genetically engineered bacteria constructed in steps (1), (2) and (3) were inoculated into a test tube containing LB liquid culture medium with a final concentration of 50 μg / mL kanamycin resistance, and cultured at 37°C and 180 rpm for 8 to 12 h. The inoculum was then inoculated into a fresh shake flask containing LB liquid culture medium with a final concentration of 50 μg / mL kanamycin resistance at a volume concentration of 1%, and cultured in a shaker at 37°C and 150 rpm for 2 to 3 h until the OD600 of the bacteria reached 0.6 to 0.8. IPTG was then added at a final concentration of 0.1 mM, and the culture was induced at 28°C for 8 to 12 h. The culture was centrifuged at 4°C and 8000 rpm for 10 min, the supernatant was discarded, and the precipitate was collected to obtain wet cells of the genetically engineered Escherichia coli, which were respectively recorded as AcN-T wet cells, ZJUTB10 wet cells and J1-M1 wet cells.

[0044] Table 1: Primer design for nitrilase gene engineering bacteria

[0045]

[0046] Example 2: Preparation of crude nitrilase solution

[0047] (1) 0.9 g of the wet cells of AcN-T, ZJUTB10 or J1-M1 obtained in Example 1 were weighed respectively, added to 30 mL of sodium phosphate buffer (200 mM, pH 7.0) and mixed thoroughly, the bacterial suspension was kept in an ice bath environment to prevent the loss of enzyme activity, and placed in an ultrasonic cell disruptor, the disruption frequency was adjusted to 1 s break and 2 s stop, the power was 240 W, and the disruption was stopped when the solution was observed to be relatively transparent. The disrupted liquid was placed in a 50 mL centrifuge tube, centrifuged at 12000 rpm, 4 ° C for 10 min, the precipitate was discarded, and the supernatant was collected to obtain the crude enzyme solution of the corresponding nitrilase.

[0048] (2) Determination of protein content: Coomassie Brilliant Blue method

[0049] Preparation of Coomassie Brilliant Blue Detection Solution: Weigh 10 mg of Coomassie Brilliant Blue G-250, dissolve in 5 mL of 95% ethanol, add 10 mL of 85% phosphoric acid, dilute to 100 mL with pure water, and store in a brown bottle for later use.

[0050] Preparation of standard curve of enzyme protein concentration: Weigh bovine serum albumin and place it in a 10mL EP tube, and prepare gradient solutions with final concentrations of 0, 0.1, 0.2, 0.3, 0.4, 0.5, and 0.6 mg / mL. Take 5μL of each gradient standard solution and each diluted sample to be tested in the deep well of the ELISA plate, add 200μL of Coomassie Brilliant Blue detection solution and mix thoroughly, use an ELISA reader to measure the absorbance at a wavelength of 595nm within 10 minutes, and draw a standard curve of the standard product, such as Figure 2In a: The standard curve equation is y=0.6698x+0.4673, and the concentration of the sample to be tested is calibrated.

[0051] Example 3: Preparation of Nitrilase CLEAs and Determination of Nitrilase Activity

[0052] (1) Preparation of nitrilase CLEAs

[0053] Default preparation process (such as Figure 2 b): react in a constant temperature water bath at 35°C and 600 rpm; or react in a 2 mL EP tube (35°C and 800 rpm metal bath), and the reaction system is reduced accordingly. 30 mL of the crude nitrilase solution obtained in Example 2 was placed in a 50 mL beaker or 1 mL of the crude nitrilase solution was placed in a 2 mL EP tube, the protein concentration of the crude enzyme solution was 5 mg / mL, and one of the precipitants such as ammonium sulfate, acetonitrile, ethanol and acetone was first added, and the protein was precipitated for 10 min; secondly, one of the surfactants such as betaine, fatty acid glyceride, F127 and Tween was added, and the protein was aggregated for 10 min; then, one of the cross-linking agents such as 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), glutaraldehyde (GA), pectin (Pectin), polyethyleneimine (PEI) was added, and the protein was cross-linked for a certain period of time; finally, one of the stabilizers such as lysine, tyrosine, serine and bovine serum albumin was added, and the protein was stabilized for 10 min. After the reaction, the solution was washed with water for 3-5 times, and the precipitate was obtained by centrifugation at 4°C and 8000 rpm for 10 min, which was the nitrilase CLEAs, and stored in a -20°C refrigerator for use.

[0054] (2) Detection method and determination of nitrilase activity

[0055] Definition of enzyme activity: The enzyme activity of nitrilase AcN-T is defined as the amount of enzyme required to catalyze 1-cyanocyclohexylacetonitrile to produce 1 μmol of 1-cyanocyclohexylacetic acid per minute at 35°C and pH 7.0, which is defined as 1U; the enzyme activity of nitrilase ZJUTB10 is defined as the amount of enzyme required to catalyze racemic o-chloromandelonitrile to produce 1 μmol of (R)-o-chloromandelic acid per minute at 35°C and pH 8.0, which is defined as 1U. Nitrilase J1-M1 acts to degrade nitrile substances, and its activity is not measured, nor is the product directly subjected to liquid phase detection.

[0056] Liquid phase detection method for the product 1-cyanocyclohexylacetic acid: using a Shimadzu liquid chromatograph SPD-16, using an XBridgeBEH C18 Column ( 5μm, 4.6mm×250mm, Waters) chromatographic column; the mobile phase was 76% aqueous buffer (0.58g / L NH4H2PO4 and 2.1g / L NaClO4, pH 1.84) and 24% acetonitrile; the UV detector wavelength was 215nm; the column temperature was 40℃; the analysis time was 20min; the flow rate was 1.0mL / min; the injection volume was 10μL.

[0057] The product (R)-2-chloromandelic acid was detected by using a Shimadzu liquid chromatography instrument SPD-16, using an XBridgeBEH C18 Column ( 5μm, 4.6mm×250mm, Waters) column; mobile phase is ammonium dihydrogen phosphate solution: methanol = 13:7 (V / V). UV detector wavelength is 228nm; column temperature is 40℃; analysis time is 15min; flow rate is 1.0mL / min; injection volume is 10μL. (R)-2-chloromandelic acid elution time is 3.8min, and racemic 2-chloromandelonitrile elution time is about 13.7min.

[0058] Free enzyme activity (U f ) Detection: 100 μL of the crude nitrilase solution obtained in Example 2 was mixed with 900 μL of phosphate buffer (200 mM, pH 7.0) to make a 1 mL system, and the mixture was incubated in a metal bath at 35°C and 800 rpm for 10 min. After the incubation, 200 mM (i.e., 0.03 g) of 1-cyanocyclohexylacetonitrile or racemic o-chloromandelonitrile was added and reacted for 10 min. After the reaction, a trace amount of 6 M hydrochloric acid solution was added to terminate the reaction. The supernatant was taken after centrifugation at 12000 rpm for 1 min and diluted 10 times for liquid phase detection analysis.

[0059] Enzyme activity of cross-linked enzyme aggregates (U I ) Detection: After the nitrilase CLEAs were dried in the shade at room temperature, the free enzyme and the protein amount (e.g., the free enzyme is 5 mg, the protein amount in the cross-linked enzyme aggregate should also be 5 mg) were weighed and resuspended in 1 mL of phosphate buffer system (200 mM, pH 7.0), and kept in a metal bath at 35°C and 800 rpm for 10 min. After the insulation, 200 mM 1-cyanocyclohexylacetonitrile or racemic o-chloromandelonitrile was added to react for 10 min. After the reaction, a trace amount of 6 M hydrochloric acid solution was added to terminate the reaction. After centrifugation at 12000 rpm for 1 min, the supernatant was taken and diluted 10 times for liquid phase detection analysis.

[0060] Calculation of enzyme activity recovery rate: HPLC was used to detect the enzyme activity of free enzyme. f The enzyme activity of CLEAs containing equal mass of protein catalyzing the same type and concentration of substrate was detected. I , calculate UI / U f The value is the enzyme activity recovery rate of CLEAs.

[0061] Example 4: Screening of precipitants

[0062] 1. Selection of precipitant type

[0063] AcN-T nitrilase CLEAs were prepared according to the method provided in Example 3. Four precipitants, ammonium sulfate, acetonitrile, ethanol and acetone, were selected, and the volume concentration of the precipitant was 17%-75%, and solutions with different final concentrations were prepared respectively. In a 2mL EP tube, 1mL of crude enzyme solution with a protein concentration of 5mg / mL and 20mg of precipitant (ammonium sulfate, acetonitrile, ethanol and acetone) were added respectively, and the mixture was allowed to stand at room temperature for 10min, and then 15mg of betaine was added, and the mixture was allowed to stand at room temperature for 10min, and then 10mg of glutaraldehyde was added, and the mixture was placed in a metal bath at 35°C and 800rpm for 1h, and finally 2mg of bovine serum albumin was added, and the mixture was reacted in a metal bath at 35°C and 800rpm for 10min, and then washed with water 3 times, and centrifuged at 4°C and 12000rpm for 10min to obtain a supernatant and a precipitate, and the supernatant was used to detect the protein concentration, and the precipitate was the cross-linked enzyme aggregate of nitrilase AcN-T.

[0064] Take a small amount of supernatant to detect protein concentration, and calculate protein precipitation rate (amount of protein formed into precipitation / total amount of protein input) by comparing the amount of enzyme input. The results are shown in Figure 3 a. The enzyme activity of the cross-linked nitrilase aggregates and the free enzyme containing equal mass of protein was detected by HPLC and the enzyme activity recovery rate was calculated. The results are shown in Figure 3 b. According to the protein precipitation rate and enzyme activity recovery rate, the optimal precipitant was ammonium sulfate.

[0065] 2. Selection of precipitant physical state and concentration

[0066] The precipitant in step 1 was changed to liquid ammonium sulfate and solid ammonium sulfate, and the added amounts were 10 g / L, 20 g / L, 30 g / L, 132 g / L, 264 g / L, and 396 g / L, respectively, based on the volume of the crude enzyme solution. Other operations were the same, and the enzyme activity recovery rates were shown in Table 1. Figure 3 As shown in c, solid ammonium sulfate with a final concentration of 20 g / L is preferably used as the protein precipitant.

[0067] Example 5: Screening of surfactants

[0068] AcN-T nitrilase CLEAs were prepared according to the method provided in Example 3. The precipitant in Example 4 was changed to solid ammonium sulfate with a volume of 20 g / L based on the volume of the crude enzyme solution, and the surfactant was selected from one of four surfactants, betaine, fatty acid glyceride, F127 and Tween, and the added amount was 5 g / L, 10 g / L, 15 g / L and 20 g / L based on the volume of the crude enzyme solution, respectively. Other operations were the same. Figure 4 The enzyme activity recovery rate is preferably 15 g / L betaine as the surfactant, at which the enzyme activity recovery rate is the highest, reaching about 75%.

[0069] Example 6: Screening of cross-linking agent and cross-linking time

[0070] 1. Selection of crosslinking agent type and concentration

[0071] AcN-T nitrilase CLEAs were prepared according to the method provided in Example 3. The precipitant in Example 4 was changed to 20 g / L solid ammonium sulfate, and the cross-linking agent was selected from one of the four cross-linking agents, EDC, glutaraldehyde (GA), pectin, and polyethyleneimine (PEI), and the added amount was 5 g / L, 10 g / L, 15 g / L, and 20 g / L, respectively, based on the volume of the crude enzyme solution. Other operations were the same. Figure 5 The optimal cross-linking agent and concentration were screened out based on the enzyme activity recovery rate. Glutaraldehyde was preferred for cross-linking proteins, and 10 g / L glutaraldehyde was more preferred.

[0072] 2. Cross-linking time selection

[0073] The precipitant in Example 4 was changed to 20 g / L solid ammonium sulfate, and the metal bath temperature at 35°C and 800 rpm for 1 h was changed to 0.5, 1.0, 1.5, 2.0, 2.0, and 3.0 h. Other operations were the same. Figure 5 In b, the enzyme activity recovery rate of 10 g / L glutaraldehyde cross-linking for 1 hour was higher, about 52%, and 10 g / L glutaraldehyde cross-linking for 1 hour was preferred.

[0074] Example 7: Screening of stabilizers

[0075] AcN-T nitrilase CLEAs were prepared according to the method provided in Example 3. The precipitant in Example 4 was changed to 20 g / L solid ammonium sulfate, and four stabilizers, lysine, tyrosine, serine and bovine serum albumin (BSA), were selected, and the added concentrations were 1 g / L, 2 g / L, 3 g / L and 4 g / L respectively based on the volume of the crude enzyme solution. Other operations were the same. Figure 6 The enzyme activity recovery rate was the highest when 2g / L bovine serum albumin was added, reaching about 60%.

[0076] Example 8: Catalytic ability of nitrilase CLEAs to different concentrations of 1-cyanocyclohexylacetonitrile

[0077] 1. AcN-T Nitrilase CLEAs

[0078] In a 2mL EP tube, 1mL of crude enzyme solution with a protein concentration of 5mg / mL and 20mg of solid ammonium sulfate were added respectively, and the mixture was allowed to stand at room temperature for 10min. Then, 15mg of betaine was added, and the mixture was allowed to stand at room temperature for 10min. Then, 10mg of glutaraldehyde was added, and the mixture was placed in a metal bath at 35℃ and 800rpm for 1h. Finally, 2mg of bovine serum albumin was added, and the mixture was reacted in a metal bath at 35℃ and 800rpm for 10min. After the reaction, the mixture was washed with water three times, and centrifuged at 4℃ and 12000rpm for 10min to obtain 8.41mg of precipitate, which was naturally dried in the shade to obtain AcN-T nitrilase CLEAs with an enzyme activity of 5.68U / mg.

[0079] 2. Catalytic reaction

[0080] Sodium phosphate buffer (200mM, pH 7.0) was used as the reaction medium, AcN-T nitrilase CLEAs and substrate 1-cyanocyclohexylacetonitrile were added to form a 30mL reaction system, and the reaction was carried out in a 35°C water bath at 600rpm. The concentration of CLEAs added was 8.41mg / mL, and the concentration of substrate added was 200mM, 500mM and 1000mM, respectively. Samples were taken every hour, the supernatant was centrifuged, and the content of product 1-CA was detected by HPLC described in Example 3.

[0081] The results are as follows Figure 7 As shown: the prepared AcN-T nitrilase CLEAs can completely convert 200mM substrate within 3h, 500mM substrate within 6h, and 1000mM substrate reaction with a conversion rate of more than 90% in 11h. According to patent CN118086272A, 100g / L resin-immobilized enzyme can completely convert 200mM substrate within 2h and 1000mM substrate within 7h. As immobilized enzymes, AcN-T nitrilase CLEAs have a lower addition amount of 8.41g / L, so the catalytic efficiency is much higher than that of resin-immobilized enzymes. The comparison of catalytic efficiency and enzyme activity shows that the CLEAs prepared by the present invention have good catalytic ability for high substrate concentrations.

[0082] Example 9: Catalytic Capacity of Nitrilases CLEAs Prepared under Different Conditions

[0083] 1. AcN-T nitrilase CLEAs (preparation condition 2)

[0084] In a 2mL EP tube, 1mL of crude enzyme solution with a protein concentration of 5mg / mL and 20mg of liquid ammonium sulfate were added respectively, and the mixture was allowed to stand at room temperature for 10min. Then, 15mg of Tween 80 was added, and the mixture was allowed to stand at room temperature for 10min. Then, 10mg of glutaraldehyde was added, and the mixture was placed in a metal bath at 35℃ and 800rpm for 1h. Finally, 2mg of lysine was added, and the mixture was reacted in a metal bath at 35℃ and 800rpm for 10min. After the reaction, the mixture was washed with water three times, and centrifuged at 4℃ and 12000rpm for 10min to obtain 6.31mg of precipitate, which was naturally dried in the shade. This was AcN-T nitrilase CLEAs (preparation condition 2) with an enzyme activity of 1.35U / mg.

[0085] The reaction system and reaction conditions for the AcN-T nitrilase CLEAs (preparation condition 2) to catalyze the hydrolysis of the substrate 1-cyanocyclohexylacetonitrile were the same as those in step 2 of Example 8. The results showed that the prepared AcN-T nitrilase CLEAs (preparation condition 2) could completely convert 200 mM substrate within 12 h, the conversion rate of the catalytic reaction of 500 mM substrate was as high as 78%, and the conversion rate of the catalytic reaction of 1000 mM substrate was only 35%.

[0086] Example 10: Catalytic ability of nitrilase CLEAs on different concentrations of o-chloromandelonitrile

[0087] ZJUTB10 nitrilase CLEAs were prepared according to the method in step 1 of Example 8, with other preparation conditions being the same, to obtain 9.89 mg of precipitate, namely ZJUTB10 nitrilase CLEAs, with an enzyme activity of 8.26 U / mg.

[0088] The obtained ZJUTB10 nitrilase CLEAs were added into sodium phosphate buffer (200 mM, pH 8.0), and then the substrate o-chloromandelonitrile was added to form a 30 mL reaction system, and the reaction was carried out in a 35°C water bath at 600 rpm. The concentration of CLEAs added was 9.89 mg / mL, and the concentration of substrate added was 100 mM, 200 mM and 500 mM, respectively. Samples were taken every hour, and the supernatant was taken by centrifugation. The content of the product (R)-o-chloromandelic acid was detected by HPLC described in Example 3. Since o-chloromandelonitrile has the characteristic of spontaneous racemization, although nitrilase can only convert (R)-o-chloromandelonitrile in racemic o-chloromandelonitrile into (R)-o-chloromandelic acid, the remaining (S)-o-chloromandelonitrile will spontaneously racemize to become racemic o-chloromandelonitrile under the weak alkaline environment of the reaction, the theoretical conversion rate of nitrilase chiral resolution of racemic o-chloromandelonitrile to (R)-o-chloromandelic acid can reach 100%.

[0089] The results are as follows Figure 8As shown: the prepared ZJUTB10 nitrilase CLEAs can completely convert 100mM substrate within 3h, 200mM substrate within 6h, and 500mM substrate within about 16h. According to Xue et al. (Advanced Synthesis & Catalysis, 2015, 357 (8): 1741-1750), the enzyme activity of ZJUTB10 enzyme is about 7U / mg, while the specific enzyme activity of ZJUTB10 nitrilase CLEAs is 8.26U / mg, and the enzyme activity recovery rate is higher. According to the same document, under the condition of batch addition of substrate, free cells can completely convert 100mM substrate within 5h and 200mM substrate within 10h, while the catalytic efficiency of AcN-T nitrilase CLEAs is much higher. Higher enzyme activity recovery and catalytic efficiency indicate that the CLEAs prepared by the present invention have better catalytic ability for high substrate concentrations.

[0090] Example 11: Batch stability of nitrilase CLEAs in the synthesis of 1-cyanocyclohexylacetic acid (1-CA)

[0091] Sodium phosphate buffer (200 mM, pH 7.0) was used as the reaction medium, and the AcN-T nitrilase CLEAs prepared by the method of Example 8 and the substrate 1-cyanocyclohexylacetonitrile were added to form a 30 mL reaction system. The reaction was carried out in a water bath at 35° C. and 600 rpm. The CLEAs were added at a concentration of 8 mg / mL and the substrate was added at a concentration of 200 mM.

[0092] The reaction was terminated after 10 hours, which was the first batch. The catalyst solution was centrifuged at 8000rpm and 4°C for 10 minutes to obtain a precipitate, which was resuspended in sodium phosphate buffer (200mM, pH 7.0) and washed three times with the buffer. The precipitate obtained was the recovered enzyme. The recovered enzyme was re-added to a 30mL reaction system, and the reaction system and reaction conditions were the same as the first batch. Similarly, the immobilized enzyme (nitrilase CLEAs) was recovered for the next batch of reactions.

[0093] The results are as follows Fig. 9 As shown: AcN-T nitrilase CLEAs was used as a catalyst, and the conversion rate could still reach about 100% after catalysis for 45 batches, and the batch stability was good.

[0094] Example 12: Application of nitrilase CLEAs in the degradation of ricinine in castor cake.

[0095] The CLEAs of J1-M1 nitrilase were prepared according to the method provided in step 1 of Example 8, with other preparation conditions being the same, and 7.5 mg of precipitate was obtained, namely, the J1-M1 nitrilase CLEAs.

[0096] About 50 mg of J1-M1 nitrilase CLEAs was put into a 250 mL conical flask, and 50 g of castor cake and 20 mL of sodium phosphate buffer (200 mM, pH 7.0) were added and mixed thoroughly, and then cultured in a water bath at 37°C and 300 rpm for 48 h. During the reaction, samples were taken at intervals of 6 h, filtered, and the filter cake was dried and crushed at 50°C. 0.5 g of the crushed sample was weighed, 20 mL of methanol was added, and the sample was shaken at 75°C and 600 rpm for 4 h. Centrifuge at 8000 rpm and 4°C for 10 min, and the supernatant was taken for liquid chromatography analysis of residual ricinine. The liquid chromatography conditions were Diamonsil TM C18 column, column temperature: 40°C, flow rate: 1 mL / min, detection wavelength: 308 nm, injection volume: 20 μL. Fig.10 As shown, after analysis, the ricinine concentration in castor cake decreased from 0.31% to 0.02% after 48 hours.

[0097] Although the present invention has been disclosed as above with preferred embodiments, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.

Claims

1. A nitrilase cross-linked enzyme aggregate, characterized in that The nitrilase cross-linked enzyme aggregate is prepared according to the following steps: (1) suspending wet cells obtained by culturing an engineered bacterium containing a nitrilase encoding gene in a pH 6-8 sodium phosphate buffer, ultrasonically disrupting the cells, centrifuging the cells, and collecting the supernatant to obtain a crude nitrilase enzyme solution; (2) In a constant temperature water bath at 35° C., a precipitant is added to a crude enzyme solution, and the solution is allowed to stand for 10 minutes to precipitate the protein; a surfactant is then added, and the solution is allowed to stand for 10 minutes to aggregate the protein; a cross-linking agent is then added, and the solution is reacted at 600 rpm for 0.5-3 hours to cross-link the protein; a stabilizer is finally added, and the solution is reacted at 600 rpm for 10 minutes to stabilize the protein, the reaction solution is washed with water for 3-5 times, centrifuged, and the precipitate is collected to obtain a cross-linked enzyme aggregate of nitrilase; the precipitant is one of ammonium sulfate, acetonitrile, ethanol, and acetone; and the stabilizer is one of bovine serum albumin, tryptophan, lysine, and tyrosine.

2. The cross-linked nitrilase enzyme aggregate of claim 1, wherein: The nitrilase in step (1) includes nitrilase AcN-T, whose nucleotide sequence is shown in SEQ ID NO.1; nitrilase ZJUTB10, whose nucleotide sequence is shown in SEQ ID NO.3; or nitrilase J1-M1, whose nucleotide sequence is shown in SEQ ID NO.

5.

3. The cross-linked nitrilase enzyme aggregate of claim 1, wherein: The ultrasonic crushing frequency in step (1) is 1s for crushing and 2s for stopping, and the power is 240W.

4. The cross-linked nitrilase enzyme aggregate of claim 1, wherein: The protein concentration of the crude enzyme solution in step (2) is 5-10 mg / mL; the amount of the precipitant added is 10-396 g / L based on the volume of the crude enzyme solution; and the amount of the stabilizer added is 1-5 g / L based on the volume of the crude enzyme solution.

5. The cross-linked nitrilase enzyme aggregate of claim 1, wherein: The surfactant in step (2) is one of betaine, fatty acid glyceride, Tween 80, and polyether Pluronic-F127; the amount of the surfactant added is 5-20 g / L based on the volume of the crude enzyme solution.

6. The cross-linked nitrilase enzyme aggregate of claim 1, wherein: The cross-linking agent in step (2) is one of glutaraldehyde, pectin, polyethyleneimine, and 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride; the amount of the cross-linking agent added is 5-20 g / L based on the volume of the crude enzyme solution.

7. Use of the nitrilase cross-linked enzyme aggregate according to claim 1 in preparing a compound intermediate, characterized in that: The compound intermediates include 1-cyanocyclohexyl acetic acid, an intermediate of gabapentin, and (R)-o-chloromandelic acid, an intermediate of clopidogrel.

8. The use according to claim 7, characterized in that The application of the nitrilase cross-linked enzyme aggregate to prepare the gabapentin intermediate 1-cyanocyclohexyl acetic acid is carried out according to the following steps: using the cross-linked enzyme aggregate prepared by the nitrilase AcN-T as a catalyst, using 1-cyanocyclohexyl acetonitrile as a substrate, and using 200mM, pH 7.0 sodium phosphate buffer as a reaction medium to form a reaction system, reacting at 35°C and 600rpm, separating and purifying the reaction liquid, recovering the catalyst for repeated use, and obtaining 1-cyanocyclohexyl acetic acid; the catalyst is added to a final concentration of 5-15g / L; and the substrate is added to a final concentration of 200-1000mM.

9. The use according to claim 7, characterized in that The application of the nitrilase cross-linked enzyme aggregate to prepare the clopidogrel intermediate (R)-o-chloromandelic acid is carried out according to the following steps: using the cross-linked enzyme aggregate prepared by the nitrilase ZJUTB10 as a catalyst, racemic o-chloromandelic acid as a substrate, and 200mM, pH 8.0 sodium phosphate buffer as a reaction medium to form a reaction system, reacting at 35°C and 600rpm, recovering the catalyst for repeated use, and obtaining the product (R)-o-chloromandelic acid; the catalyst is added to a final concentration of 5-15g / L; the substrate is added to a final concentration of 100-500mM.

10. An application of the nitrilase cross-linked enzyme aggregate according to claim 1 in degrading ricinine in castor cake, characterized in that: The application is carried out according to the following steps: a cross-linked enzyme aggregate prepared by nitrilase J1-M1 is used as a catalyst, castor cake is used as a substrate, and a 200mM sodium phosphate buffer with a pH of 7.0 is used as a reaction medium to form a reaction system, and the reaction system is cultured at 37°C and 300rpm to achieve the degradation of ricinine; the mass ratio of the catalyst to the substrate is 1:800-1000; and the volume of the buffer is 0.1-1mL / mg based on the mass of the catalyst.